Skin-targeted siRNA therapies require optimized delivery to achieve therapeutic efficacy. Here, authors show that increasing conjugate hydrophobicity enhances siRNA skin retention and gene silencing in porcine and human models while limiting systemic tissue exposure.
- Hassan H. Fakih
- Mohammad Zain UI Abideen
- Julia F. Alterman
